News & Articles

Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated

COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study

A new Prenetics Innovation Technology Centre will be established for advanced molecular diagnostics

Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall

Researchers have used Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others

The new institute aims to meet the urgent need to do more research into the antimicrobial resistance

Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is 70.4% effective when combining data from two dosing regimens

The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses

A new study has revealed psoriatic arthritis may be activated by the same trigger in different patients

These findings could lead to new preventative strategies, including diet and lifestyle interventions

The study has uncovered a genetic vulnerability present in nearly 10% percent of all breast cancers tumors

New research published in Nature Immunology show strong T cell responses in patients recovered from COVID-19

Researchers from the University of Oxford’s Department of Zoology have discovered that moderate doses of antibiotics restrict the emergence of antibiotic-resistant bacteria

This evidence-based programme, called SHAPE Recovery, builds on an outreach programme shown to reduce rates of PTSD and depression

When patients report muscle-related symptoms, blood tests can provide reassurance about continuing statin therapy to help prevent heart attacks and strokes

Anti-osteoporotic medicine, romosozumab, may lead to excess cardiovascular complications